Vivorte Overview

  • Founded
  • 2008
  • Status
  • Private
  • Employees
  • 13
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $2.4M
Latest Deal Amount
  • Investors
  • 6

Vivorte General Information


Developer of orthopedic devices designed to improve the bone strength of patients. The company's devices use regenerative technologies to develop bone grafting and expediting the healing process, enabling surgeons, and hospitals to advance the standard of care in a cost-effective manner.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Services
Primary Office
  • 1044 East Chestnut Street
  • Louisville, KY 40204
  • United States
+1 (502) 000-0000

Vivorte Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Vivorte Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 31-Mar-2021 $2.4M 00.00 Completed Generating Revenue
5. Later Stage VC 05-Sep-2018 00.000 00.00 Completed Generating Revenue
4. Early Stage VC 25-Jul-2013 00.000 00.00 Completed Generating Revenue
3. Accelerator/Incubator 00.000 Completed Startup
2. Seed Round 01-Jan-2012 $2.5M $2.88M Completed Startup
1. Angel (individual) 10-Nov-2009 $375K $375K Completed Startup
To view Vivorte’s complete valuation and funding history, request access »

Vivorte Executive Team (3)

Name Title Board Seat Contact Info
Mark Wagner Chief Executive Officer & President
Michael Voor Ph.D Co-Founder & Chief Scientific Officer
Ruth Voor Co-Founder & Board Member
To view Vivorte’s complete executive team members history, request access »

Vivorte Board Members (5)

Name Representing Role Since
Robert Saunders Self Board Member 000 0000
Ruth Voor Vivorte Co-Founder & Board Member 000 0000
Steve Peoples MD Vivorte Board Member & FDA Advisor 000 0000
Tyree Wilburn Yearling Management Board Member 000 0000
William Scheessele Self Board Member 000 0000
To view Vivorte’s complete board members history, request access »

Vivorte Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vivorte Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Anchorage Angels Angel Group Minority 000 0000 000000 0
CommonWealth Seed Capital Venture Capital Minority 000 0000 000000 0
Yearling Management Venture Capital Minority 000 0000 000000 0
Mammoth View Venture Capital Minority 000 0000 000000 0
Connetic Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »